+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novo Nordisk A/S - logo

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Key products include diabetes care medications and devices. Novo Nordisk is also involved with hemostasis management, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 40,000 employees in 75 countries, and markets its products in more than 180 countries.

From
From
From
Glucose Monitoring Devices Market Report and Forecast 2024-2032 - Product Thumbnail Image

Glucose Monitoring Devices Market Report and Forecast 2024-2032

  • Report
  • September 2023
  • 160 Pages
  • Global
From
Insulin Pen Market - Product Thumbnail Image

Insulin Pen Market

  • Report
  • February 2024
  • 78 Pages
  • Global
From
Continuous Glucose Monitoring Market 2023-2027 - Product Thumbnail Image

Continuous Glucose Monitoring Market 2023-2027

  • Report
  • December 2022
  • 158 Pages
  • Global
From
Blood Glucose Monitoring Devices Market Outlook, 2028 - Product Thumbnail Image

Blood Glucose Monitoring Devices Market Outlook, 2028

  • Report
  • November 2023
  • 190 Pages
  • Global
From
From
Insulin Pens - Global Strategic Business Report - Product Thumbnail Image

Insulin Pens - Global Strategic Business Report

  • Report
  • November 2024
  • 92 Pages
  • Global
From
Blood Glucose Monitoring (BGM) Devices - A Global Market Overview - Product Thumbnail Image

Blood Glucose Monitoring (BGM) Devices - A Global Market Overview

  • Report
  • February 2020
  • 452 Pages
  • Global
From
Loading Indicator